National Comprehensive Cancer Network



About NCCN

Neuroendocrine Tumors Panel - Disclosures as of 12/17/2012

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict

Al B. Benson III, MD, FACP, FASCO

None

Agendia BV;
Bayer HealthCare;
Daiichi- Sankyo Co.;
Eli Lilly and Company;
Genentech, Inc.;
Genomic Health, Inc.;
National Cancer Institute;
Precision Therapeutics, Inc.

None

None

None

Emily Bergsland, MD

None

Novartis Pharmaceuticals Corporation

None

None

None

Jordan D. Berlin, MD

None

AstraZeneca Pharmaceuticals LP;
Celgene Corporation;
Eli Lilly and Company;
Novartis Pharmaceuticals Corporation;
symphogen;
Roche Laboratories, Inc.

None

None

None

Lawrence S. Blaszkowsky, MD

Genentech, Inc.;
GlaxoSmithKline

None

None

None

None

Michael A. Choti, MD, MBA

None

Bayer HealthCare;
Bristol-Myers Squibb Company;
Genentech, Inc.;
sanofi-aventis U.S.

None

None

None

Orlo H. Clark, MD

Xoma

Xoma

None

None

None

Mary Dwyer, MS

None

None

None

None

None

James Eason, MD

None

None

None

None

None

Lyska Emerson, MD

None

None

None

None

None

Paul F. Engstrom, MD, FACP

None

None

None

None

None

Deborah Freedman-Cass, PhD

None

None

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Whitney S. Goldner, MD

None

None

None

None

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Martin J. Heslin, MD

None

None

None

None

None

Fouad Kandeel, MD, PhD

None

None

None

None

None

Matthew H. Kulke, MD

None

Novartis Pharmaceuticals Corporation;
Ipsen;
Lexicon;
Pfizer Inc.

None

None

None

Pamela L. Kunz, MD

None

None

None

None

None

Boris W. Kuvshinoff, MD, MBA

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Jeffrey F. Moley, MD

AstraZeneca Pharmaceuticals LP;
Exelixis Inc.

Exelixis Inc.

None

None

None

Venu G. Pillarisetty, MD

None

None

None

None

None

Leonard Saltz, MD

Amgen Inc.;
Bayer HealthCare;
Bristol-Myers Squibb Company;
CureTech Ltd.;
Eli Lilly and Company;
Genentech, Inc.;
ImClone Systems Incorporated;
National Cancer Institute;
OSI Pharmaceuticals, Inc.;
Astellis;
Biothera;
Immunomedex;
Pfizer Inc.;
Roche Laboratories, Inc.;
Synta Pharmaceuticals Corp.;
Taiho Parmaceuticals Co., Ltd.

Bayer HealthCare;
CureTech Ltd.;
Genentech, Inc.;
Genomic Health, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Roche Laboratories, Inc.;
Taiho Parmaceuticals Co., Ltd.

None

None

None

Manisha H. Shah, MD

National Cancer Institute;
Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation

None

None

None

Jonathan R. Strosberg, MD

Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

Genentech, Inc.;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

None

Jean-Nicolas Vauthey, MD

None

None

None

None

None

Rebekah White, MD

None

None

None

None

None

James C. Yao, MD

None

National Cancer Institute;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.

None

None

None